Tajima K - Search Results

1

Pulmonary sarcoidosis and antiphospholipid syndrome.

Takahashi F, Toba M, Takahashi K, Tominaga S, Sato K, Morio Y, Nakao Y, Tajima K, Miura K, Uekusa T, Fukuchi Y. Takahashi F, et al. Among authors: tajima k. Respirology. 2006 Jul;11(4):506-8. doi: 10.1111/j.1440-1843.2006.00880.x. Respirology. 2006. PMID: 16771926

2

[A case of non-small cell lung cancer accompanied with hemorrhage after chemotherapy including gemcitabine].

Nagashima O, Tajima K, Ito J, Kajiyama Y, Shimanuki Y, Miura K, Sato K, Miyamoto H, Uekusa T, Suzuki T, Takahashi K, Fukuchi Y. Nagashima O, et al. Among authors: tajima k. Nihon Kokyuki Gakkai Zasshi. 2006 Mar;44(3):215-9. Nihon Kokyuki Gakkai Zasshi. 2006. PMID: 16617866 Japanese.

3

Osteopontin is involved in the formation of malignant pleural effusion in lung cancer.

Cui R, Takahashi F, Ohashi R, Yoshioka M, Gu T, Tajima K, Unnoura T, Iwakami S, Hirama M, Ishiwata T, Iwase A, Takahashi K. Cui R, et al. Among authors: tajima k. Lung Cancer. 2009 Mar;63(3):368-74. doi: 10.1016/j.lungcan.2008.06.020. Epub 2008 Aug 26. Lung Cancer. 2009. PMID: 18752867

4

ERC/mesothelin as a marker for chemotherapeutic response in patients with mesothelioma.

Tajima K, Hirama M, Shiomi K, Ishiwata T, Yoshioka M, Iwase A, Iwakami S, Yamazaki M, Toba M, Tobino K, Sugano K, Ichikawa M, Hagiwara Y, Takahashi K, Hino O. Tajima K, et al. Anticancer Res. 2008 Nov-Dec;28(6B):3933-6. Anticancer Res. 2008. PMID: 19192652 Free article.

5

Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer.

Gu T, Ohashi R, Cui R, Tajima K, Yoshioka M, Iwakami S, Sasaki S, Shinohara A, Matsukawa T, Kobayashi J, Inaba Y, Takahashi K. Gu T, et al. Among authors: tajima k. Lung Cancer. 2009 Nov;66(2):176-83. doi: 10.1016/j.lungcan.2009.02.004. Epub 2009 Mar 13. Lung Cancer. 2009. PMID: 19285749

6

Osteopontin modulates malignant pleural mesothelioma cell functions in vitro.

Ohashi R, Tajima K, Takahashi F, Cui R, Gu T, Shimizu K, Nishio K, Fukuoka K, Nakano T, Takahashi K. Ohashi R, et al. Among authors: tajima k. Anticancer Res. 2009 Jun;29(6):2205-14. Anticancer Res. 2009. PMID: 19528482 Free article.

7

Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells.

Tajima K, Ohashi R, Sekido Y, Hida T, Nara T, Hashimoto M, Iwakami S, Minakata K, Yae T, Takahashi F, Saya H, Takahashi K. Tajima K, et al. Oncogene. 2010 Apr 1;29(13):1941-51. doi: 10.1038/onc.2009.478. Epub 2010 Jan 18. Oncogene. 2010. PMID: 20101228

8

Distinct roles of cholinergic receptors in small cell lung cancer cells.

Zhang S, Togo S, Minakata K, Gu T, Ohashi R, Tajima K, Murakami A, Iwakami S, Zhang J, Xie C, Takahashi K. Zhang S, et al. Among authors: tajima k. Anticancer Res. 2010 Jan;30(1):97-106. Anticancer Res. 2010. PMID: 20150622

9

Sex hormones alter Th1 responses and enhance granuloma formation in the lung.

Tajima K, Miura K, Ishiwata T, Takahashi F, Yoshioka M, Minakata K, Murakami A, Sasaki S, Iwakami S, Annoura T, Hashimoto M, Nara T, Takahashi K. Tajima K, et al. Respiration. 2011;81(6):491-8. doi: 10.1159/000324295. Epub 2011 Apr 1. Respiration. 2011. PMID: 21454951 Free article.

10

Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors.

Minakata K, Takahashi F, Nara T, Hashimoto M, Tajima K, Murakami A, Nurwidya F, Yae S, Koizumi F, Moriyama H, Seyama K, Nishio K, Takahashi K. Minakata K, et al. Among authors: tajima k. Cancer Sci. 2012 Nov;103(11):1946-54. doi: 10.1111/j.1349-7006.2012.02408.x. Epub 2012 Sep 14. Cancer Sci. 2012. PMID: 22863020 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,649 results

Search Page